On the possible use of a new boron compound, hydroxysalicylhydroxamato boron(III), and ultrasound in the treatment of female mice bearing the Ehrlichascites carcinoma cells

Citation
P. Ghosh et al., On the possible use of a new boron compound, hydroxysalicylhydroxamato boron(III), and ultrasound in the treatment of female mice bearing the Ehrlichascites carcinoma cells, NEOPLASMA, 45(6), 1998, pp. 384-388
Citations number
11
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
NEOPLASMA
ISSN journal
00282685 → ACNP
Volume
45
Issue
6
Year of publication
1998
Pages
384 - 388
Database
ISI
SICI code
0028-2685(1998)45:6<384:OTPUOA>2.0.ZU;2-A
Abstract
The inhibitory effects of a new boron compound hydroxy salicylhydroxamato b oron (III) (SHB) and ultrasound of frequency 25 KHz (US) on the growth of a scites tumor in female Swiss mice were studied by monitoring the survival a nd the tumor growth in the treated tumor bearing mice and also the transpla ntability and the DNA synthesis in the treated tumor (Ehrlich ascites carci noma) cells. While SHB alone produced a highly significant antitumor activi ty, US alone produced a small but significant effect. The combination of SH B and US produced significantly greater antitumor activity than SHB alone. The mechanisms of SHB and US actionary are discussed.